Gladstone Institutes
About Gladstone Institutes
Gladstone is an independent, nonprofit life science research organization located in the epicenter of biomedical and technological innovation in the San Francisco Bay Area. Gladstone has created a research model that disrupts how science is done, funds big ideas, and attracts the brightest minds. Gladstone Institutes leads the way for innovative research in the biomedical field. We always seek dedicated and talented individuals to join our team.
Scientists know that using a diversity of approaches is often the most efficient strategy for solving a problem. New and different perspectives engender the very innovation that Gladstone prizes. This is one of the many reasons why we value diversity at Gladstone—be that a diversity of race, culture, religion, mental or physical ability, heritage, age, gender, sexual orientation or other characteristics. Our employees hail from more than 30 countries around the globe and we seek to hire the best and brightest for our diverse team of scientists and administrators. Career opportunities are available in both our administrative offices and our research areas.
Our Benefits
Gladstone offers eligible employees—and their dependents—a comprehensive range of benefits, including health insurance, retirement savings, and professional development.
Highlights
- Health and Retirement
- A choice of medical plans, flexible spending account, and retirement account options that include employer contributions help you take care of your health and your future.
- Time Away from Work
- More than just vacation days, our paid and unpaid leave policies offer flexibility to help you confront different stages of life including maternity and paternity leave, as well as other types of family leave.
- Professional Development
- Gladstone encourages employees to seek the skills they need to remain at the forefront of their profession. By supporting professional development workshops and continuing education, Gladstone provides employees with the resources they need to evolve in their role and in their career.
- Gladstone Cares
- A specially selected suite of benefits to support you in and out of the workplace. Includes resources for dealing with the many stages of life to specific coverage for family planning, and back-up child or elder care coverage.
138 articles about Gladstone Institutes
-
Study Suggests Catalyst for Human Brain Evolution
4/28/2023
More than a million years ago, large chunks of the human genome were rearranged—a chance event during egg or sperm formation that led to the deletion, duplication, or reversal of sections of DNA.
-
Sugar Rush: Scientists Discover Key Role of Glucose in Brain Activity
4/18/2023
The human brain has a sweet tooth, burning through nearly one quarter of the body's sugar energy, or glucose, each day.
-
Impact of Key Alzheimer's Protein Depends on Type of Brain Cell in Which It Is Produced
2/21/2023
Gladstone researchers show that ApoE4 from neurons plays a much more critical role in the disease than previously thought
-
New Partnership between Gladstone Institutes and CZ Biohub
10/26/2022
Gladstone Institutes and the Chan Zuckerberg Biohub signed an affiliation agreement to increase their research collaboration.
-
Gladstone Data Scientist Elected to the National Academy of Medicine
10/17/2022
Data scientist and statistician Katie Pollard, PhD, director of the Gladstone Institute of Data Science and Biotechnology, has been elected to the National Academy of Medicine, one of the highest honors in health and medicine.
-
Gladstone Institutes Joins the Parker Institute for Cancer Immunotherapy Network
9/28/2022
Gladstone Institutes has partnered with the Parker Institute for Cancer Immunotherapy, the leading network of immuno-oncology expertise in the world, to establish a new research center focused on using genomics and CRISPR technology to program the human immune system to treat cancer.
-
Scientists Engineer DNA "Receipt Book" To Store Cells' History
7/27/2022
If you want to track a person's activities for a day, you could call them up every ten minutes and ask what they're doing.
-
What Makes Omicron More Infectious Than Other COVID-19 Variants
7/20/2022
As the Omicron variant of SARS-CoV-2 spread rapidly around the globe earlier this year, researchers at Gladstone Institutes, UC Berkeley, and the Innovative Genomics Institute used virus-like particles to identify which parts of the virus are responsible for its increased infectivity and spread.
-
BETting On COVID-19: Study Probes Role of BET Proteins in Coronavirus Infection
7/19/2022
A while ago, some researchers had suggested that blocking a set of proteins, known as bromodomain and extraterminal proteins, might be a way to fight COVID-19.
-
Pathway Deep in the Brain Makes It Resilient after Injury
7/6/2022
For days, and even years, after someone suffers a stroke or traumatic brain injury, they have an increased risk of developing epilepsy.
-
Throwing Drug Resistance for a Loop
5/12/2022
Viruses in the herpesvirus family are leading causes of birth defects, blindness, and failed organ transplants worldwide.
-
Zeroing in on a New Treatment for Autism and Epilepsy
4/27/2022
Children with Dravet syndrome, a severe form of epilepsy that begins in infancy, experience seizures, usually for their entire life.
-
Researchers may have found a potential treatment for congenital heart defects in a surprising source: an over-the-counter cough suppressant. Know more here. -
Getting to the Heart of Complex Disease
2/18/2022
Nearly 1 percent of all children are born with congenital heart disease—a range of potentially life-threatening problems with the structure and function of their hearts.
-
A New Class of Antiviral Therapy Could Treat COVID-19
12/9/2021
As the SARS-CoV-2 virus mutates, new variants emerge that can better evade immunity and spread more widely.
-
It Takes Guts to Make a Heart
12/2/2021
At the earliest stages of a new human life, cells that seem identical begin to divide into distinct types that eventually grow into a diverse array of tissues and organs.
-
Maintaining Balance in the Brain
10/19/2021
Gladstone scientists help explain how reducing the protein tau can prevent abnormal brain activity associated with Alzheimer's disease, autism, and epilepsy
-
Gladstone Neuroscience Researcher Elected to the National Academy of Medicine
10/19/2021
Lennart Mucke, MD, founding director of the Gladstone Institute of Neurological Disease and senior investigator at Gladstone Institutes, has been elected to the National Academy of Medicine.
-
The NIH revealed that bumetanide, a drug typically used as a diuretic, maybe a potential treatment for those genetically at risk for Alzheimer's. Know more about it here. -
Cancer Immunologist Karin Pelka Joins Gladstone Institutes
9/14/2021
For the immune system, which protects us from bacteria, viruses, and other pathogens, communication is of utmost importance.